Extranodal marginal zone lymphoma: a case report and review of the literature.
The World Health Organization (WHO) defines extranodal marginal zone lymphoma (MZL) as an indolent B-cell lymphoma. This disease involves a heterogeneous group of B-cell tumors that occurs primarily within the lymph nodes, spleen, or extranodal tissues. Initial MZL treatment consists of chemotherapy and/or radiotherapy and is associated with a high survival rate when detected early. This article highlights an unusual case of extranodal MZL in the parotid area.
Yepes
Juan F
JF
School of Dentistry, University of Pennsylvania, Philadelphia, USA.
Alawi
Faizan
F
Stanton
David C
DC
Stoopler
Eric T
ET
D000368:Aged; D003937:Diagnosis, Differential; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000473:pathology*; D008297:Male; D009959:Oropharyngeal Neoplasms / Q000473:pathology*